|
1
|
Dominici LS, Morrow M, Mittendorf E,
Bellon J and King TA: Trends and controversies in multidisciplinary
care of the patient with breast cancer. Curr Probl Surg.
53:559–595. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Yeo SG, Kim J, Kwak GH, Kim JY, Park K,
Kim ES and Han S: Accelerated partial breast irradiation using
multicatheter brachytherapy for select early-stage breast cancer:
Local control and toxicity. Radiat Oncol. 5(56)2010.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Martel S, Maurer C, Lambertini M, Ponde N
and De Azambuja E: Breast cancer treatment-induced cardiotoxicity.
Expert Opin Drug Saf. 16:1021–1038. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Meattini I, Guenzi M, Fozza A, Vidali C,
Rovea P, Meacci F and Livi L: Overview on cardiac, pulmonary and
cutaneous toxicity in patients treated with adjuvant radiotherapy
for breast cancer. Breast Cancer. 24:52–62. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Petersen C and Würschmidt F: Late toxicity
of radiotherapy: A problem or a challenge for the radiation
oncologist? Breast Care (Basel). 6:369–374. 2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Donker M, van Tienhoven G, Straver ME,
Meijnen P, van de Velde CJ, Mansel RE, Cataliotti L, Westenberg AH,
Klinkenbijl JH, Orzalesi L, et al: Radiotherapy or surgery of the
axilla after a positive sentinel node in breast cancer (EORTC
10981-22023 AMAROS): A randomised, multicentre, open-label, phase 3
non-inferiority trial. Lancet Oncol. 15:1303–1310. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Warren LE, Miller CL, Horick N, Skolny MN,
Jammallo LS, Sadek BT, Shenouda MN, O'Toole JA, MacDonald SM,
Specht MC and Taghian AG: The impact of radiation therapy on the
risk of lymphedema after treatment for breast cancer: A prospective
cohort study. Int J Radiat Oncol Biol Phys. 88:565–571.
2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Rockson SG: Lymphedema after breast cancer
treatment. N Engl J Med. 379:1937–1944. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kilbreath SL, Refshauge KM, Beith JM, Ward
LC, Ung OA, Dylke ES, French JR, Yee J, Koelmeyer L and Gaitatzis
K: Risk factors for lymphoedema in women with breast cancer: A
large prospective cohort. Breast. 28:29–36. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Gross JP, Sachdev S, Helenowski IB, Lipps
D, Hayes JP, Donnelly ED and Strauss JB: Radiation therapy field
design and lymphedema risk after regional nodal irradiation for
breast cancer. Int J Radiat Oncol Biol Phys. 102:71–78.
2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Gera R, Kasem A and Mokbel K: Can complete
axillary node dissection be safely omitted in patients with early
breast cancer when the sentinel node biopsy is positive for
malignancy? An update for clinical practice. In Vivo. 32:1301–1307.
2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kestin LL, Sharpe MB, Frazier RC, Vicini
FA, Yan D, Matter RC, Martinez AA and Wong JW: Intensity modulation
to improve dose uniformity with tangential breast radiotherapy:
Initial clinical experience. Int J Radiat Oncol Biol Phys.
48:1559–1568. 2000.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Jo IY, Kim SW and Son SH: Dosimetric
evaluation of the skin-sparing effects of 3-dimensional conformal
radiotherapy and intensity-modulated radiotherapy for left breast
cancer. Oncotarget. 8:3059–3063. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Mansouri S, Naim A, Glaria L and Marsiglia
H: Dosimetric evaluation of 3-D conformal and intensity-modulated
radiotherapy for breast cancer after conservative surgery. Asian
Pac J Cancer Prev. 15:4727–4732. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Vugts G, Maaskant-Braat AJ, Voogd AC, van
Riet YE, Luiten EJ, Rutgers EJ, Rutten HJ, Roumen RM and
Nieuwenhuijzen GA: Repeat sentinel node biopsy should be considered
in patients with locally recurrent breast cancer. Breast Cancer Res
Treat. 153:549–556. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Giuliano AE, Ballman KV, McCall L, Beitsch
PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW,
Blumencranz PW, et al: Effect of axillary dissection vs no axillary
dissection on 10-year overall survival among women with invasive
breast cancer and sentinel node metastasis: The ACOSOG Z0011
(Alliance) randomized clinical trial. JAMA. 318:918–926.
2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Galimberti V, Cole BF, Viale G, Veronesi
P, Vicini E, Intra M, Mazzarol G, Massarut S, Zgajnar J, Taffurelli
M, et al: Axillary dissection versus no axillary dissection in
patients with breast cancer and sentinel-node micrometastases
(IBCSG 23-01): 10-year follow-up of a randomised, controlled phase
3 trial. Lancet Oncol. 19:1385–1393. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Dogan N, Cuttino L, Lloyd R, Bump EA and
Arthur DW: Optimized dose coverage of regional lymph nodes in
breast cancer: The role of intensity-modulated radiotherapy. Int J
Radiat Oncol Biol Phys. 68:1238–1250. 2007.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kataria T, Bisht SS, Gupta D, Goyal S,
Jassal K, Abhishek A, Sharma K, Pareek P, Kumar V, Jain S, et al:
Incidental radiation to axilla in early breast cancer treated with
intensity modulated tangents and comparison with conventional and
3D conformal tangents. Breast. 22:1125–1129. 2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Henke G, Knauer M, Ribi K, Hayoz S, Gérard
MA, Ruhstaller T, Zwahlen DR, Muenst S, Ackerknecht M, Hawle H, et
al: Tailored axillary surgery with or without axillary lymph node
dissection followed by radiotherapy in patients with clinically
node-positive breast cancer (TAXIS): Study protocol for a
multicenter, randomized phase-III trial. Trials.
19(667)2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Rastogi K, Sharma S, Gupta S, Agarwal N,
Bhaskar S and Jain S: Dosimetric comparison of IMRT versus 3DCRT
for post-mastectomy chest wall irradiation. Radiat Oncol J.
36:71–78. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Balaji K, Subramanian B, Yadav P, Anu
Radha C and Ramasubramanian V: Radiation therapy for breast cancer.
Med Dosim. 41:253–257. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Teoh M, Clark CH, Wood K, Whitaker S and
Nisbet A: Volumetric modulated arc therapy: A review of current
literature and clinical use in practice. Br J Radiol. 84:967–996.
2011.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Gentile MS, Usman AA, Neuschler EI,
Sathiaseelan V, Hayes JP and Small W Jr: Contouring guidelines for
the axillary lymph nodes for the delivery of radiation therapy in
breast cancer: Evaluation of the RTOG breast cancer atlas. Int J
Radiat Oncol Biol Phys. 93:257–265. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Badakhshi H, Kaul D, Nadobny J, Wille B,
Sehouli J and Budach V: Image-guided volumetric modulated arc
therapy for breast cancer: A feasibility study and plan comparison
with three-dimensional conformal and intensity-modulated
radiotherapy. Br J Radiol. 86(20130515)2013.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Penha TR, Botter B, Heuts EM, Voogd AC,
von Meyenfeldt MF and van der Hulst RR: Quality of life in patients
with breast cancer-related lymphedema and reconstructive breast
surgery. J Reconstr Microsurg. 32:484–490. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Ganz PA: The quality of life after breast
cancer-solving the problem of lymphedema. N Engl J Med.
340:383–385. 1999.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Cornelissen AJM, Kool M, Keuter XHA, Heuts
EM, Piatkowski de Grzymala AA, van der Hulst RRWJ and Qiu SS:
Quality of life questionnaires in breast cancer-related lymphedema
patients: Review of the literature. Lymphat Res Biol. 16:134–139.
2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Fadda G, Massazza G, Zucca S, Durzu S,
Meleddu G, Possanzini M and Farace P: Quasi-VMAT in high-grade
glioma radiation therapy. Strahlenther Onkol. 189:367–371.
2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Jolly D, Alahakone D and Meyer J: A
rapidArc planning strategy for prostate with simultaneous
integrated boost. J Appl Clin Med Phys. 12(3320)2010.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Rudat V, Alaradi AA, Mohamed A, Ai-Yahya K
and Altuwaijri S: Tangential beam IMRT versus tangential beam
3D-CRT of the chest wall in postmastectomy breast cancer patients:
A dosimetric comparison. Radiat Oncol. 6(26)2011.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Xie X, Ouyang S, Wang H, Yang W, Jin H, Hu
B and Shen L: Dosimetric comparison of left-sided whole breast
irradiation with 3D-CRT, IP-IMRT and hybrid IMRT. Oncol Rep.
31:2195–2205. 2014.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zhang L, Yang ZZ, Chen XX, Tuan J, Ma JL,
Mei X, Yu XL, Zhou ZR, Shao ZM, Liu GY and Guo XM: Dose coverage of
axillary level I-III areas during whole breast irradiation with
simplified intensity modulated radiation therapy in early stage
breast cancer patients. Oncotarget. 6:18183–18191. 2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Lee J, Kim SW and Son SH: Dosimetric
evaluation of incidental irradiation to the axilla during whole
breast radiotherapy for patients with left-sided early breast
cancer in the IMRT era. Medicine (Baltimore).
95(e4036)2016.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Reed DR, Lindsley SK, Mann GN,
Austin-Seymour M, Korssjoen T, Anderson BO and Moe R: Axillary
lymph node dose with tangential breast irradiation. Int J Radiat
Oncol Biol Phys. 61:358–364. 2005.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Krasin M, McCall A, King S, Olson M and
Emami B: Evaluation of a standard breast tangent technique: A
dose-volume analysis of tangential irradiation using
three-dimensional tools. Int J Radiat Oncol Biol Phys. 47:327–333.
2000.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Fisher B, Redmond C, Poisson R, Margolese
R, Wolmark N, Wickerham L, Fisher E, Deutsch M, Caplan R, Pilch Y,
et al: Eight-year results of a randomized clinical trial comparing
total mastectomy and lumpectomy with or without irradiation in the
treatment of breast cancer. N Engl J Med. 320:822–828.
1989.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Hall EJ and Wuu CS: Radiation-induced
second cancers: The impact of 3D-CRT and IMRT. Int J Radiat Oncol
Biol Phys. 56:83–88. 2003.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Han EY, Paudel N, Sung J, Yoon M, Chung WK
and Kim DW: Estimation of the risk of secondary malignancy arising
from whole-breast irradiation: Comparison of five radiotherapy
modalities, including TomoHDA. Oncotarget. 7:22960–22969.
2016.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Alongi F, Giaj-Levra N, Fiorentino A,
Mazzola R, Fersino S, Ricchetti F and Ruggieri R: Low-dose bath
with volumetric modulated arc therapy in breast cancer: ‘Much ado
about nothing?’. Tumori. 102:335–336. 2016.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Darby SC, McGale P, Taylor CW and Peto R:
Long-term mortality from heart disease and lung cancer after
radiotherapy for early breast cancer: Prospective cohort study of
about 300,000 women in US SEER cancer registries. Lancet Oncol.
6:557–565. 2005.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Chen J, Hong J, Zou X, Lv W, Guo F, Hong H
and Zhang W: Association between absolute volumes of lung spared
from low-dose irradiation and radiation-induced lung injury after
intensity-modulated radiotherapy in lung cancer: A retrospective
analysis. J Radiat Res. 56:883–888. 2015.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Ni L, Koshy M, Connell P, Pitroda S,
Golden DW, Al-Hallaq H, Hubert G, Kauffman G, McCall A and Malik R:
Heart V5 predicts cardiac events in unresectable lung cancer
patients undergoing chemoradiation. J Thorac Dis. 11:2229–2239.
2019.PubMed/NCBI View Article : Google Scholar
|
